TreeWAS – Variant ID: rs11154271

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z09.2 Follow-up examination after chemotherapy for other conditions	0.013	0.987	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.012	0.988	0.000
M47.89 Other spondylosis (Site unspecified)	0.000	0.989	0.011
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.989	0.011
L53.9 Erythematous condition, unspecified	0.000	0.990	0.010
E28.2 Polycystic ovarian syndrome	0.000	0.990	0.010
D68.8 Other specified coagulation defects	0.000	0.991	0.009
E28 Ovarian dysfunction	0.000	0.991	0.009
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.000	0.991	0.009
E23.0 Hypopituitarism	0.000	0.991	0.009
E23 Hypofunction and other disorders of pituitary gland	0.000	0.992	0.008
E22 Hyperfunction of pituitary gland	0.000	0.992	0.008
E20-E35 Disorders of other endocrine glands	0.000	0.992	0.008
E22.0 Acromegaly and pituitary gigantism	0.000	0.992	0.008
E28.3 Primary ovarian failure	0.000	0.992	0.008
E26 Hyperaldosteronism	0.000	0.992	0.008
I35.1 Aortic (valve) insufficiency	0.000	0.993	0.007
E20 Hypoparathyroidism	0.000	0.993	0.007
E87.7 Fluid overload	0.007	0.993	0.000
E28.9 Ovarian dysfunction, unspecified	0.000	0.993	0.007
E28.8 Other ovarian dysfunction	0.000	0.993	0.007
E28.1 Androgen excess	0.000	0.993	0.007
E28.0 Oestrogen excess	0.000	0.993	0.007
C83.3 Large cell (diffuse)	0.000	0.993	0.007
E22.1 Hyperprolactinaemia	0.000	0.993	0.007
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.993	0.007
F99 Mental disorder, not otherwise specified	0.000	0.993	0.007
E23.6 Other disorders of pituitary gland	0.000	0.993	0.007
E29 Testicular dysfunction	0.000	0.993	0.007
E26.0 Primary hyperaldosteronism	0.000	0.993	0.006
E26.9 Hyperaldosteronism, unspecified	0.000	0.994	0.006
E23.2 Diabetes insipidus	0.000	0.994	0.006
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.994	0.006
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.994	0.006
E23.1 Drug-induced hypopituitarism	0.000	0.994	0.006
E32 Diseases of thymus	0.000	0.994	0.006
E25 Adrenogenital disorders	0.000	0.994	0.006
E22.8 Other hyperfunction of pituitary gland	0.000	0.994	0.006
E20.9 Hypoparathyroidism, unspecified	0.000	0.994	0.006
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.994	0.006
E30 Disorders of puberty, not elsewhere classified	0.000	0.994	0.006
E23.7 Disorder of pituitary gland, unspecified	0.000	0.994	0.006
E26.8 Other hyperaldosteronism	0.000	0.994	0.006
E26.1 Secondary hyperaldosteronism	0.000	0.994	0.006
E31 Polyglandular dysfunction	0.000	0.994	0.006
E24 Cushing's syndrome	0.000	0.994	0.005
M79.8 Other specified soft tissue disorders	0.000	0.995	0.005
E20.1 Pseudohypoparathyroidism	0.000	0.995	0.005
E34 Other endocrine disorders	0.000	0.995	0.005
E20.8 Other hypoparathyroidism	0.000	0.995	0.005
E29.1 Testicular hypofunction	0.000	0.995	0.005
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.995	0.005
E20.0 Idiopathic hypoparathyroidism	0.000	0.995	0.005
M79.86 Other specified soft tissue disorders (Lower leg)	0.000	0.995	0.005
K70.4 Alcoholic hepatic failure	0.005	0.995	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.000	0.995	0.005
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.995	0.005
L53 Other erythematous conditions	0.000	0.995	0.005
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.000	0.995	0.005
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.995	0.005
C83.0 Small cell (diffuse)	0.000	0.995	0.005
E29.8 Other testicular dysfunction	0.000	0.995	0.005
E29.0 Testicular hyperfunction	0.000	0.995	0.005
H50.9 Strabismus, unspecified	0.005	0.995	0.000
E29.9 Testicular dysfunction, unspecified	0.000	0.995	0.005
E32.9 Disease of thymus, unspecified	0.000	0.995	0.005
E32.8 Other diseases of thymus	0.000	0.995	0.005
E27 Other disorders of adrenal gland	0.000	0.995	0.005
E32.1 Abscess of thymus	0.000	0.995	0.005
E32.0 Persistent hyperplasia of thymus	0.000	0.995	0.005
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.000	0.995	0.005
E25.9 Adrenogenital disorder, unspecified	0.000	0.995	0.005
E25.8 Other adrenogenital disorders	0.000	0.995	0.005
K43 Ventral hernia	0.000	0.995	0.005
E30.9 Disorder of puberty, unspecified	0.000	0.995	0.005
E30.8 Other disorders of puberty	0.000	0.995	0.005
E30.1 Precocious puberty	0.000	0.995	0.005
E30.0 Delayed puberty	0.000	0.995	0.005
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.995	0.005
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.995	0.005
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.995	0.005
D68.2 Hereditary deficiency of other clotting factors	0.000	0.995	0.005
D68 Other coagulation defects	0.000	0.995	0.005
M79.88 Other specified soft tissue disorders (Other)	0.000	0.995	0.005
T43.5 Other and unspecified antipsychotics and neuroleptics	0.005	0.995	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.005	0.995	0.000
E24.8 Other Cushing's syndrome	0.000	0.995	0.004
M79.82 Other specified soft tissue disorders (Upper arm)	0.000	0.995	0.004
K70 Alcoholic liver disease	0.004	0.996	0.000
C83.7 Burkitt's tumour	0.000	0.996	0.004
Y86 Sequelae of other accidents	0.004	0.996	0.000
E31.9 Polyglandular dysfunction, unspecified	0.000	0.996	0.004
E31.8 Other polyglandular dysfunction	0.000	0.996	0.004
E31.1 Polyglandular hyperfunction	0.000	0.996	0.004
K70.0 Alcoholic fatty liver	0.004	0.996	0.000
E34.9 Endocrine disorder, unspecified	0.000	0.996	0.004
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.996	0.004
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.996	0.004
E24.3 Ectopic ACTH syndrome	0.000	0.996	0.004
E24.1 Nelson's syndrome	0.000	0.996	0.004
D68.6 Other Thrombophilia	0.000	0.996	0.004
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.996	0.004
E34.5 Androgen resistance syndrome	0.000	0.996	0.004
E34.4 Constitutional tall stature	0.000	0.996	0.004
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.996	0.004
E34.1 Other hypersecretion of intestinal hormones	0.000	0.996	0.004
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.996	0.004
M79.80 Other specified soft tissue disorders (Multiple sites)	0.000	0.996	0.004
K70.3 Alcoholic cirrhosis of liver	0.004	0.996	0.000
C83.6 Undifferentiated (diffuse)	0.000	0.996	0.004
C83.4 Immunoblastic (diffuse)	0.000	0.996	0.004
F31 Bipolar affective disorder	0.000	0.996	0.004
C83.5 Lymphoblastic (diffuse)	0.000	0.996	0.004
C85.1 B-cell lymphoma, unspecified	0.000	0.996	0.004
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.996	0.004
T43.0 Tricyclic and tetracyclic antidepressants	0.004	0.996	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.996	0.004
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
M79.81 Other specified soft tissue disorders (Shoulder region)	0.000	0.996	0.004
C83.2 Mixed small and large cell (diffuse)	0.000	0.996	0.004
E24.0 Pituitary-dependent Cushing's disease	0.000	0.996	0.004
L53.8 Other specified erythematous conditions	0.000	0.996	0.004
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.996	0.004
E34.8 Other specified endocrine disorders	0.000	0.996	0.004
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.996	0.004
E24.9 Cushing's syndrome, unspecified	0.000	0.996	0.004
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
L53.3 Other chronic figurate erythema	0.000	0.996	0.004
L53.2 Erythema marginatum	0.000	0.996	0.004
L53.1 Erythema annulare centrifugum	0.000	0.996	0.004
E34.0 Carcinoid syndrome	0.000	0.996	0.004
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.996	0.004
C82.3 Follicular lymphoma grade IIIa	0.000	0.996	0.004
E31.0 Autoimmune polyglandular failure	0.000	0.996	0.003
L53.0 Toxic erythema	0.000	0.996	0.004
D68.0 Von Willebrand's disease	0.000	0.996	0.004
E24.2 Drug-induced Cushing's syndrome	0.000	0.996	0.003
E27.5 Adrenomedullary hyperfunction	0.000	0.996	0.004
E27.0 Other adrenocortical overactivity	0.000	0.996	0.004
K70.9 Alcoholic liver disease, unspecified	0.004	0.996	0.000
E27.9 Disorder of adrenal gland, unspecified	0.000	0.996	0.004
E34.3 Short stature, not elsewhere classified	0.000	0.996	0.003
K43.7 Other and unspecified ventral hernia with gangrene	0.000	0.996	0.004
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene	0.000	0.996	0.004
K43.5 Parastomal hernia without obstruction or gangrene	0.000	0.996	0.004
K43.4 Parastomal hernia with gangrene	0.000	0.996	0.004
K43.3 Parastomal hernia with obstruction, without gangrene	0.000	0.996	0.004
K43.2 Incisional hernia without obstruction or gangrene	0.000	0.996	0.004
R22.1 Localised swelling, mass and lump, neck	0.004	0.996	0.000
M77.91 Enthesopathy, unspecified (Shoulder region)	0.000	0.996	0.004
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.996	0.004
F31.9 Bipolar affective disorder, unspecified	0.000	0.996	0.004
D68.1 Hereditary factor XI deficiency	0.000	0.996	0.004
H65.9 Nonsuppurative otitis media, unspecified	0.004	0.996	0.000
M25.55 Pain in joint (Pelvic region and thigh)	0.000	0.996	0.004
C88 Malignant immunoproliferative diseases	0.000	0.996	0.003
E27.8 Other specified disorders of adrenal gland	0.000	0.996	0.003
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.996	0.003
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.000	0.996	0.003
M79.89 Other specified soft tissue disorders (Site unspecified)	0.000	0.996	0.003
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.996	0.004
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.997	0.003
C82.2 Large cell, follicular	0.000	0.997	0.003
E27.1 Primary adrenocortical insufficiency	0.000	0.997	0.003
C82.4 Follicular lymphoma grade IIIb	0.000	0.997	0.003
C82.6 Cutaneous follicle centre lymphoma	0.000	0.997	0.003
C82.5 Diffuse follicle centre lymphoma	0.000	0.997	0.003
C82.0 Small cleaved cell, follicular	0.000	0.997	0.003
K70.2 Alcoholic fibrosis and sclerosis of liver	0.003	0.997	0.000
Z95.2 Presence of prosthetic heart valve	0.000	0.997	0.003
D68.4 Acquired coagulation factor deficiency	0.000	0.997	0.003
K43.1 Ventral hernia with gangrene	0.000	0.997	0.003
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.997	0.003
H50.1 Divergent concomitant strabismus	0.003	0.997	0.000
C83.1 Small cleaved cell (diffuse)	0.000	0.997	0.003
E27.2 Addisonian crisis	0.000	0.997	0.003
F31.7 Bipolar affective disorder, currently in remission	0.000	0.997	0.003
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.997	0.003
C95 Leukaemia of unspecified cell type	0.000	0.997	0.003
C85.0 Lymphosarcoma	0.000	0.997	0.003
Z95.3 Presence of xenogenic heart valve	0.000	0.997	0.003
C93 Monocytic leukaemia	0.000	0.997	0.003
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.997	0.003
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.997	0.003
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.997	0.003
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.997	0.003
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.997	0.003
C91 Lymphoid leukaemia	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.997	0.003
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
F31.8 Other bipolar affective disorders	0.000	0.997	0.003
M79.84 Other specified soft tissue disorders (Hand)	0.000	0.997	0.003
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
K04.5 Chronic apical periodontitis	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
C79 Secondary malignant neoplasm of other sites	0.000	0.997	0.003
J81 Pulmonary oedema	0.000	0.997	0.003
S82.50 Fracture of medial malleolus (closed)	0.000	0.997	0.003
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.997	0.003
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.003	0.997	0.000
C94 Other leukaemias of specified cell type	0.000	0.997	0.003
C91.9 Lymphoid leukaemia, unspecified	0.000	0.997	0.003
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.997	0.003
R22.2 Localised swelling, mass and lump, trunk	0.003	0.997	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.003	0.997	0.000
K70.1 Alcoholic hepatitis	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
C79.2 Secondary malignant neoplasm of skin	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
C95.9 Leukaemia, unspecified	0.000	0.997	0.003
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.997	0.003
I61.8 Other intracerebral haemorrhage	0.003	0.997	0.000
M77.9 Enthesopathy, unspecified	0.000	0.997	0.003
M84.1 Nonunion of fracture [pseudarthrosis]	0.003	0.997	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.997	0.003
Z45.0 Adjustment and management of cardiac pacemaker	0.003	0.997	0.000
F99-F99 Unspecified mental disorder	0.000	0.997	0.003
M77.97 Enthesopathy, unspecified (Ankle and foot)	0.000	0.997	0.003
M79.83 Other specified soft tissue disorders (Forearm)	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.997	0.003
C88.7 Other malignant immunoproliferative diseases	0.000	0.997	0.003
C88.3 Immunoproliferative small intestinal disease	0.000	0.997	0.003
C88.2 Gamma heavy chain disease	0.000	0.997	0.003
C88.1 Alpha heavy chain disease	0.000	0.997	0.003
C86 Other specified types of T/NK-cell lymphoma	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.003	0.997	0.000
C84.5 Other and unspecified T-cell lymphomas	0.000	0.997	0.003
D68.5 Primary Thrombophilia	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
M77.94 Enthesopathy, unspecified (Hand)	0.000	0.997	0.003
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.003	0.997	0.000
H50 Other strabismus	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
C91.5 Adult T-cell leukaemia	0.000	0.997	0.003
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
C84.0 Mycosis fungoides	0.000	0.997	0.003
C90.1 Plasma cell leukaemia	0.000	0.997	0.003
J39.8 Other specified diseases of upper respiratory tract	0.000	0.997	0.003
C81 Hodgkin's disease	0.000	0.997	0.003
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.997	0.003
C93.1 Chronic monocytic leukaemia	0.000	0.997	0.002
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.997	0.002
C91.1 Chronic lymphocytic leukaemia	0.000	0.997	0.003
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.997	0.002
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.997	0.002
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.997	0.002
C84.3 Lymphoepithelioid lymphoma	0.000	0.997	0.002
C84.2 T-zone lymphoma	0.000	0.997	0.002
C84.1 Sezary's diease	0.000	0.997	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.997	0.003
C93.9 Monocytic leukaemia, unspecified	0.000	0.997	0.002
C93.7 Other monocytic leukaemia	0.000	0.997	0.002
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.997	0.002
C93.2 Subacute monocytic leukaemia	0.000	0.997	0.002
C93.0 Acute monocytic leukaemia	0.000	0.997	0.002
C95.7 Other leukaemia of unspecified cell type	0.000	0.997	0.002
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.997	0.002
T42.0 Hydantoin derivatives	0.003	0.997	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.997	0.002
T42.1 Iminostilbenes	0.003	0.997	0.000
Z91.5 Personal history of self-harm	0.003	0.997	0.000
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.003	0.997	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.997	0.002
C91.7 Other lymphoid leukaemia	0.000	0.997	0.002
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.997	0.002
C91.3 Prolymphocytic leukaemia	0.000	0.997	0.002
C91.2 Subacute lymphocytic leukaemia	0.000	0.997	0.002
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.997	0.002
C96.8 Histiocytic sarcoma	0.000	0.997	0.002
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.997	0.002
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.997	0.002
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.997	0.002
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.997	0.002
C96.3 True histiocytic lymphoma	0.000	0.997	0.002
C96.2 Malignant mast cell tumour	0.000	0.997	0.002
C96.1 Malignant histiocytosis	0.000	0.997	0.002
C96.0 Letterer-Siwe disease	0.000	0.997	0.002
I60-I69 Cerebrovascular diseases	0.003	0.997	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.003	0.997	0.000
T42.4 Benzodiazepines	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.997	0.002
R22.7 Localised swelling, mass and lump, multiple sites	0.002	0.997	0.000
T40.1 Heroin	0.002	0.997	0.000
T42.3 Barbiturates	0.002	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.997	0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.002	0.997	0.000
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.003	0.997	0.000
I60 Subarachnoid haemorrhage	0.003	0.997	0.000
T40.5 Cocaine	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
D68.9 Coagulation defect, unspecified	0.000	0.998	0.002
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
M77.96 Enthesopathy, unspecified (Lower leg)	0.000	0.998	0.002
C94.7 Other specified leukaemias	0.000	0.998	0.002
C94.5 Acute myelofibrosis	0.000	0.998	0.002
C94.3 Mast cell leukaemia	0.000	0.998	0.002
C94.2 Acute megakaryoblastic leukaemia	0.000	0.998	0.002
C94.1 Chronic erythraemia	0.000	0.998	0.002
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.998	0.002
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
C81.1 Nodular sclerosis	0.000	0.998	0.002
C95.0 Acute leukaemia of unspecified cell type	0.000	0.998	0.002
O61.0 Failed medical induction of labour	0.000	0.998	0.002
R22.4 Localised swelling, mass and lump, lower limb	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.002	0.998	0.000
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.002	0.998	0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.002	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.998	0.002
J01.9 Acute sinusitis, unspecified	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.002	0.998	0.000
M77.99 Enthesopathy, unspecified (Site unspecified)	0.000	0.998	0.002
M77.98 Enthesopathy, unspecified (Other)	0.000	0.998	0.002
M77.90 Enthesopathy, unspecified (Multiple sites)	0.000	0.998	0.002
Y54.3 Benzothiadiazine derivatives	0.000	0.998	0.002
I69.0 Sequelae of subarachnoid haemorrhage	0.002	0.998	0.000
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
I61 Intracerebral haemorrhage	0.002	0.998	0.000
G82.1 Spastic paraplegia	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
I35 Nonrheumatic aortic valve disorders	0.000	0.998	0.002
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.998	0.002
C86.4 Blastic NK-cell lymphoma	0.000	0.998	0.002
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.998	0.002
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.998	0.002
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.998	0.002
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.998	0.002
H50.5 Heterophoria	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.998	0.002
H50.2 Vertical strabismus	0.002	0.998	0.000
I72.3 Aneurysm of iliac artery	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.002	0.998	0.000
T39.2 Pyrazolone derivatives	0.002	0.998	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.002	0.998	0.000
H50.6 Mechanical strabismus	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
M25.87 Other specified joint disorders (Ankle and foot)	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
C79.6 Secondary malignant neoplasm of ovary	0.000	0.998	0.002
C94.4 Acute panmyelosis	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
B25.9 Cytomegaloviral disease, unspecified	0.002	0.998	0.000
C90.3 Solitary plasmacytoma	0.000	0.998	0.002
C91.0 Acute lymphoblastic leukaemia	0.000	0.998	0.002
T40.3 Methadone	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
M77.92 Enthesopathy, unspecified (Upper arm)	0.000	0.998	0.002
R22.3 Localised swelling, mass and lump, upper limb	0.002	0.998	0.000
S30.2 Contusion of external genital organs	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.998	0.002
C81.3 Lymphocytic depletion	0.000	0.998	0.002
E21.2 Other hyperparathyroidism	0.000	0.998	0.002
H50.3 Intermittent heterotropia	0.002	0.998	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
M77.93 Enthesopathy, unspecified (Forearm)	0.000	0.998	0.002
I60.4 Subarachnoid haemorrhage from basilar artery	0.002	0.998	0.000
K66.1 Haemoperitoneum	0.000	0.998	0.002
M41.96 Scoliosis, unspecified (Lumbar region)	0.000	0.998	0.002
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.002	0.998	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.002	0.998	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
I62 Other nontraumatic intracranial haemorrhage	0.002	0.998	0.000
C81.2 Mixed cellularity	0.000	0.998	0.002
H50.8 Other specified strabismus	0.002	0.998	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
S02.50 Fracture of tooth (closed)	0.000	0.998	0.002
H50.4 Other and unspecified heterotropia	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.000	0.998	0.002
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
C81.7 Other Hodgkin's disease	0.000	0.998	0.002
S30.0 Contusion of lower back and pelvis	0.002	0.998	0.000
T40.2 Other opioids	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.002	0.998	0.000
M77.95 Enthesopathy, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
I60.5 Subarachnoid haemorrhage from vertebral artery	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.000	0.998	0.002
C90.0 Multiple myeloma	0.000	0.998	0.002
I35.8 Other aortic valve disorders	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
C91.4 Hairy-cell leukaemia	0.000	0.998	0.002
I60.8 Other subarachnoid haemorrhage	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.002	0.998	0.000
G58.9 Mononeuropathy, unspecified	0.002	0.998	0.000
C81.0 Lymphocytic predominance	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.998	0.001
E21.4 Other specified disorders of parathyroid gland	0.000	0.998	0.002
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.002	0.998	0.000
K72.9 Hepatic failure, unspecified	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
I62.1 Nontraumatic extradural haemorrhage	0.002	0.998	0.000
T36.0 Penicillins	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
I65.1 Occlusion and stenosis of basilar artery	0.002	0.998	0.000
M41.9 Scoliosis, unspecified	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.002	0.998	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.002	0.998	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.002	0.998	0.000
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.002	0.998	0.000
K57.1 Diverticular disease of small intestine without perforation or abscess	0.000	0.998	0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.998	0.002
G82.5 Tetraplegia, unspecified	0.000	0.998	0.002
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations